Company intelligence / Profile preview
Nika Pharmaceuticals
Henderson, Nevada, United Statesnikapharmaceuticals.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Nika Pharmaceuticals has developed a portfolio including six injectable drugs—two of which have successfully undergone clinical trials with positive treatment outcomes—as well as four tablet-form drugs and eleven dietary supplements. Its lead program, ITV‑1, has shown curative effects in volunteers suffering from AIDS and cancer beyond formal trial statistics. The company is expanding manufacturing capabilities for broader distribution
- Therapeutic areas
- OncologyEndocrinologyImmunologyInfectious Diseases
- Modalities
- Small moleculeProtein
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Immunotech Laboratories BGDistribution partners in Nigeria, Ukraine, UAE, Iraq, Jordan, Syria for ITV‑1 product lines
Beyond the preview
Go deeper on Nika Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nika Pharmaceuticals.